Osage Partners related stories
All articles and analysis
ExecOnline fetches $18 mln Series CExecOnline, a provider of certificate-bearing leadership and development programs in partnership with elite business schools, has secured $18 million in Series C funding. ABS Capital Partners led the round with participation from New Spring Capital, Osage Partners, Kaplan Inc and New Atlantic Ventures. In addition to the funding, Ralph Terkowitz, a general partner with ABS Capital, will join the EXO board of directors.
- DrayNow picks up $5 mln Series A
DrayNow, a provider of technology-driven solutions for the intermodal freight industry, has raised $5 million in Series A funding. Comcast Ventures led the round with participation from Osage Venture Partners.
- Investor group commits $30 mln to merged OvaScience and Millendo
An investor syndicate that includes New Enterprise Associates, Frazier Healthcare Partners, Roche Venture Fund, Innobio managed by Bpifrance, Osage University Partners, Altitude Life Science Ventures, Adams Street Partners, and Longwood Fund has committed to invest $30 million in the newly merged OvaScienceSM and Millendo Therapeutics. OvaScience is a developer of treatments for women and couples struggling with infertility while Millendo Therapeutics Inc is a clinical-stage biopharmaceutical company focused on treating orphan endocrine diseases. The newly combined company is expected to operate under the name Millendo Therapeutics and trade on the NASDAQ under the ticker symbol "MLND."
- StreetLight Data raises $10 mln from Osage University Partners, ENGIE New Ventures, Deutsche Telekom Capital Partners, others
StreetLight Data said it raised $10 million of Series C capital in an oversubscribed round backed by Osage University Partners, ENGIE New Ventures, Deutsche Telekom Capital Partners and others.
- VC-backed VividCortex taps Ali as CEO
VividCortex, a provider of database analytics software, has named Amena Ali as CEO and a member of its board of directors. Previously, Ali worked at Whisker Labs where she was chief revenue officer. VividCortex's backers include New Enterprise Associates, Battery Ventures, Osage Venture Partners and Bull City Venture Partners.
- Precision BioScience snags $110 mln Series B
Durham, North Carolina-based Precision BioScience, a genome editing system provider, has raised $110 million in Series B financing. ArrowMark Partners led the round with participation from other investors that included Franklin Templeton Investments, Cowen Healthcare Investments, Brace Pharma Capital, Adage Capital Management, Cormorant Asset Management, Gilead Sciences, Vivo Capital, Alexandria Venture Investments, Ridgeback Capital, Agent Capital, Leerink Partners, venBio, F-Prime and Osage University Partners.
- VC-backed Aptinyx goes public
Aptinyx Inc, a biopharmaceutical company focused on developing treatments for neurologic disorders, has debuted its IPO after pricing its near 6.4 million shares at $16 per share. The stock began trading June 21, 2018 on the NASDAQ under the ticker symbol "APTX." J.P. Morgan, Cowen, Leerink Partners and BMO Capital Markets are the lead underwriters. Aptinyx's pre-IPO backers include Bain Capital Life Sciences, Adage Capital, Nan Fung Life Sciences, Rock Springs Capital, New Leaf Venture Partners, Frazier Healthcare Partners, Osage University Partners, Adams Street Partners and Beecken Petty O’Keefe & Company.